Antibody Therapy Market
A recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics.
After conducting thorough research on the historical and current growth parameters of the Antibody Therapy Market, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The Antibody Therapy Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Type
Monoclonal Antibodies
Oncology, Autoimmune Disease
Infectious Disease
Other
Antibody Drug Conjugates
By End User
Hospitals
Speciality Centers
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the Antibody Therapy Market includes the market proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Antibody Therapy Market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Antibody Therapy Market in this chapter, which will help them understand basic information about the Antibody Therapy Market. This section also highlights the inclusions and exclusions, which help the reader, understand the scope of the Antibody Therapy Market report.
Chapter 03 – Market Background
The associated industry assessment of the Antibody Therapy Market is carried out in this section. The macroeconomic factors affecting the growth of the Antibody Therapy Market are provided in this section and the impact of these macroeconomic indicators on the Antibody Therapy Market is analyzed. The processing overview and technological advancements in the Antibody Therapy Market are also provided.
Chapter 04 – Antibody Therapy Market Value Chain
Profit margins at each level of the Antibody Therapy Market are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the Antibody Therapy Market.
Chapter 05 – Market Dynamics
The drivers and restraints impacting the growth of the Antibody Therapy Market are explained in this chapter. Opportunities and ongoing trends in the Antibody Therapy Market are also comprehensively discussed.
Chapter 06 – Antibody Therapy Market - Pricing Analysis
This chapter includes global as well as regional pricing analysis by product type. The pricing influencing factors are also explained in this chapter. The readers can understand the manufacturer level, distributor level as well as retail level pricing analysis for 2022 and 2032.
Chapter 07 – Antibody Therapy Market Demand Analysis and Forecast 2022-2029
This chapter includes a detailed analysis of the historical Antibody Therapy Market (2014-2021), along with an opportunity analysis for the forecast period (2022-2032). Readers can also find the absolute $ opportunity for the current year (2022) and incremental opportunity for the forecast period (2022-2032).
Chapter 8 – Global Antibody Therapy Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Type
Based on the type, the Antibody Therapy Market is segmented into Monoclonal Antibodies (Oncology, Autoimmune Disease, Infectious Disease, Other. In this chapter, readers can find information about key trends and developments in the Antibody Therapy Market and market attractive analysis based on the type.
Chapter 9 – Global Antibody Therapy Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By End User
Based on the end user, the Antibody Therapy Market is segmented into Hospitals, Specialty Centers, Others. In this chapter, readers can find information about key trends and developments in the Antibody Therapy Market and market attractive analysis based on end user.
Chapter 10 – Global Antibody Therapy Market Analysis (2014-2021) & Opportunity Assessment (2022-2032), By Region
This chapter explains how the Antibody Therapy Market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Southeast Asia & Pacific, China, India, Japan and the Middle East & Africa (MEA).
Chapter 11 – North America Antibody Therapy Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
This chapter includes detailed analysis of the growth of the North America Antibody Therapy Market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends and market growth based on Product Type, End User, and country of Antibody Therapy in North America.
Chapter 12 – Latin America Antibody Therapy Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Antibody Therapy Market. This chapter also includes the growth prospects of the Antibody Therapy Market in leading LATAM countries such as Brazil, Mexico, and rest of the Latin America region.
Chapter 13 – Eastern Europe Antibody Therapy Market Analysis 2014-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Eastern Europe Antibody Therapy Market, along with a country-wise assessment that includes Poland, Czech Republic and Rest of Eastern Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Eastern Europe.
Chapter 14 – Western Europe Antibody Therapy Market Analysis 2014-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Western Europe Antibody Therapy Market, along with a country-wise assessment that includes the U.K., France, Germany and Rest of Western Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Western Europe.
Chapter 15 – APEJ Antibody Therapy Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find thorough information about the growth parameters of the APEJ Antibody Therapy Market during the period 2022-2032.
Chapter 16 – Japan Antibody Therapy Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
Readers can find important factors that can make a huge impact on the growth of the Antibody Therapy Market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of drivers, restraints, and trends in the Japan Antibody Therapy Market.
Chapter 17 – MEA Antibody Therapy Market Analysis 2014-2021 & Opportunity Assessment 2022-2032
This chapter provides information on how the Antibody Therapy Market will grow in the major countries in MEA region, such as GCC Countries, South Africa and Rest of MEA during the period 2022-2029.
Chapter 18 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Antibody Therapy Market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments.
Chapter 19 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 20 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Antibody Therapy Market.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Fact.MR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Antibody Therapy Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
- 4. Market Background and Foundation Data Points
- 4.1. Global Protective Coatings Market (US$ Mn)
- 4.2. Antibody Therapy Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Protective Coatings Market Growth
- 4.5.3. Antibody Therapy Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Antibody Therapy Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
- 5. Key Success Factors
- 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
- 6. Global Antibody Therapy Market Demand Analysis 2015-2021 and Forecast, 2022-2032
- 6.1. Historical Market Analysis, 2015-2021
- 6.2. Current and Future Market Projections, 2022-2032
- 6.3. Y-o-Y Growth Trend Analysis
- 7. Global Antibody Therapy Market Value Analysis 2015-2021 and Forecast, 2022-2032
- 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Type
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
- 8.3.1. Monoclonal Antibodies (mAbs)
- 8.3.1.1. Oncology
- 8.3.1.2. Autoimmune Diseases
- 8.3.1.3. Infectious Diseases
- 8.3.1.4. Others
- 8.3.2. Antibody-drug Conjugates (ADCs)
- 8.4. Market Attractiveness Analysis By Type
- 9. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By End-use
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2015-2021
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
- 9.3.1. Hospitals
- 9.3.2. Specialty Centers
- 9.3.3. Others
- 9.4. Market Attractiveness Analysis By End-use
- 10. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Region
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
- 10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
- 10.4. Market Attractiveness Analysis By Region
- 11. North America Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 11.1. Introduction
- 11.2. Pricing Analysis
- 11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 11.4.1. By Country
- 11.4.1.1. U.S.
- 11.4.1.2. Canada
- 11.4.1.3. Rest of North America
- 11.4.2. By Type
- 11.4.3. By End-use
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Type
- 11.5.3. By End-use
- 12. Latin America Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 12.1. Introduction
- 12.2. Pricing Analysis
- 12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 12.4.1. By Country
- 12.4.1.1. Brazil
- 12.4.1.2. Mexico
- 12.4.1.3. Rest of Latin America
- 12.4.2. By Type
- 12.4.3. By End-use
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Type
- 12.5.3. By End-use
- 13. Europe Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 13.4.1. By Country
- 13.4.1.1. Germany
- 13.4.1.2. France
- 13.4.1.3. U.K.
- 13.4.1.4. Italy
- 13.4.1.5. Benelux
- 13.4.1.6. Nordic Countries
- 13.4.1.7. Rest of Europe
- 13.4.2. By Type
- 13.4.3. By End-use
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Type
- 13.5.3. By End-use
- 14. Asia Pacific Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 14.4.1. By Country
- 14.4.1.1. China
- 14.4.1.2. Japan
- 14.4.1.3. South Korea
- 14.4.1.4. Rest of Asia Pacific
- 14.4.2. By Type
- 14.4.3. By End-use
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Type
- 14.5.3. By End-use
- 15. Middle East and Africa Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
- 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
- 15.4.1. By Country
- 15.4.1.1. GCC Countries
- 15.4.1.2. South Africa
- 15.4.1.3. Turkey
- 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Type
- 15.4.3. By End-use
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Type
- 15.5.3. By End-use
- 16. Key Countries Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032
- 16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
- 16.2. US Antibody Therapy Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.2.2.1. By Type
- 16.2.2.2. By End-use
- 16.3. Canada Antibody Therapy Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.3.2.1. By Type
- 16.3.2.2. By End-use
- 16.4. Mexico Antibody Therapy Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.4.2.1. By Type
- 16.4.2.2. By End-use
- 16.5. Brazil Antibody Therapy Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.5.2.1. By Type
- 16.5.2.2. By End-use
- 16.6. Germany Antibody Therapy Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.6.2.1. By Type
- 16.6.2.2. By End-use
- 16.7. France Antibody Therapy Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.7.2.1. By Type
- 16.7.2.2. By End-use
- 16.8. Italy Antibody Therapy Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.8.2.1. By Type
- 16.8.2.2. By End-use
- 16.9. BENELUX Antibody Therapy Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.9.2.1. By Type
- 16.9.2.2. By End-use
- 16.10. UK Antibody Therapy Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.10.2.1. By Type
- 16.10.2.2. By End-use
- 16.11. Nordic Countries Antibody Therapy Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.11.2.1. By Type
- 16.11.2.2. By End-use
- 16.12. China Antibody Therapy Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.12.2.1. By Type
- 16.12.2.2. By End-use
- 16.13. Japan Antibody Therapy Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.13.2.1. By Type
- 16.13.2.2. By End-use
- 16.14. South Korea Antibody Therapy Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.14.2.1. By Type
- 16.14.2.2. By End-use
- 16.15. GCC Countries Antibody Therapy Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.15.2.1. By Type
- 16.15.2.2. By End-use
- 16.16. South Africa Antibody Therapy Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.16.2.1. By Type
- 16.16.2.2. By End-use
- 16.17. Turkey Antibody Therapy Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
- 16.17.2.1. By Type
- 16.17.2.2. By End-use
- 16.17.3. Competition Landscape and Player Concentration in the Country
- 17. Market Structure Analysis
- 17.1. Market Analysis by Tier of Companies
- 17.2. Market Concentration
- 17.3. Market Share Analysis of Top Players
- 17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players
- 18. Competition Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Competition Deep Dive
- 18.3.1. F. Hoffmann-La Roche Ltd
- 18.3.1.1. Overview
- 18.3.1.2. Product Portfolio
- 18.3.1.3. Sales Footprint
- 18.3.1.4. Strategy Overview
- 18.3.2. AbbVie Inc
- 18.3.2.1. Overview
- 18.3.2.2. Product Portfolio
- 18.3.2.3. Sales Footprint
- 18.3.2.4. Strategy Overview
- 18.3.3. Amgen Inc
- 18.3.3.1. Overview
- 18.3.3.2. Product Portfolio
- 18.3.3.3. Sales Footprint
- 18.3.3.4. Strategy Overview
- 18.3.4. Bristol-Myers Squibb Company
- 18.3.4.1. Overview
- 18.3.4.2. Product Portfolio
- 18.3.4.3. Sales Footprint
- 18.3.4.4. Strategy Overview
- 18.3.5. Johnson & Johnson Services, Inc
- 18.3.5.1. Overview
- 18.3.5.2. Product Portfolio
- 18.3.5.3. Sales Footprint
- 18.3.5.4. Strategy Overview
- 18.3.6. Seagen
- 18.3.6.1. Overview
- 18.3.6.2. Product Portfolio
- 18.3.6.3. Sales Footprint
- 18.3.6.4. Strategy Overview
- 18.3.7. Merck & Co. Inc
- 18.3.7.1. Overview
- 18.3.7.2. Product Portfolio
- 18.3.7.3. Sales Footprint
- 18.3.7.4. Strategy Overview
- 18.3.8. Regeneron Pharmaceuticals Inc
- 18.3.8.1. Overview
- 18.3.8.2. Product Portfolio
- 18.3.8.3. Sales Footprint
- 18.3.8.4. Strategy Overview
- 18.3.9. Novartis AG
- 18.3.9.1. Overview
- 18.3.9.2. Product Portfolio
- 18.3.9.3. Sales Footprint
- 18.3.9.4. Strategy Overview
- 18.3.10. AstraZeneca
- 18.3.10.1. Overview
- 18.3.10.2. Product Portfolio
- 18.3.10.3. Sales Footprint
- 18.3.10.4. Strategy Overview
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook